-
Uncategorized3 months agoStudy supports Treg enhancement as dementia treatment
A research study led by Dr Alireza Faridar and Dr Stanley Appel at the Houston Methodist Neurological Institute has demonstrated the involvement of the peripheral immune...
-
Uncategorized3 months agoThe next generation of CAR-T cell therapies
Drug Discovery World Editor Reece Armstrong speaks to Dr Jan Davidson-Moncada, Chief Medical Officer at Imviva Biotech about the development of CAR-T cell therapies and the company’s activities in this space. ...
-
Uncategorized3 months agoResearch uncovers how prostate cancer cells resist treatment
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some...
-
Uncategorized3 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis has agreed a deal with Synnovation Therapeutics to acquire Pikavation Therapeutics and its portfolio of PI3Kα inhibitor programmes, including SNV4818. Pikavation is a wholly-owned subsidiary...
-
Uncategorized3 months agoLaigo Bio raises $17m to advance oncology pipeline
Biotech company Laigo Bio has completed the second close of its seed financing round with an additional $5.5 million bringing the total investment to $17 million. Laigo will...
-
Uncategorized3 months agoNHS health data should be used for clinical trial recruitment, says ABPI
The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit...
-
Uncategorized3 months agoLast chance to register: Understand LC-MS quantification strategies for proteins
A new event, hosted by DDW and supported by Evotec, will explore cutting-edge LC-MS-based bioanalytical approaches tailored for the quantitative analysis of therapeutic proteins, such as...
-
Uncategorized3 months ago
‘Zombie cells’ return from the dead — after a genome transplant
Post Content
-
Uncategorized3 months agoRoche leads AI drug discovery with new NVIDIA deal
Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totalling more than 3,500 GPUs, following an expansion of its global AI infrastructure. The company...
-
Uncategorized3 months agoEMA launches tools to accelerate development of medicines
The European Medicines Agency (EMA) has launched three major new features of PRIME, the Agency’s scheme to enhance support for the development of medicines targeting an...
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
